Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUT vs MRNA✓SelectedUSD · MRNAHUT vs MRNA performance historyLatest closeAs of+1.39%11/17
Stock and ETF performance explorer

HUT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+751.9%
MRNA return
+840.0%
Excess return
-88.1%
Maximum drawdown
-95.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.4%-3.9%+5.3%+1.8%
7D-4.9%-17.6%+12.6%-2.8%
30D-20.3%-5.1%-15.2%-20.2%
3M-38.7%+220.8%-259.5%-52.5%
6M-47.3%+321.7%-369.0%-61.7%
YTD+17.5%+601.3%-583.8%-22.4%
1Y+43.2%+735.2%-692.1%-8.2%
3Y+468.1%+170.5%+297.6%+318.0%
5Y-20.0%-14.6%-5.4%-33.9%
All+751.9%+840.0%-88.1%+769.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling